Vaxcyte's total assets for Q2 2025 were $3.31B, a decrease of -2.15% from the previous quarter. PCVX total liabilities were $234.03M for the fiscal quarter, a 31.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.